These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37977204)

  • 21. Antibiotics for acute bacterial conjunctivitis.
    Sheikh A; Hurwitz B; Cave J
    Cochrane Database Syst Rev; 2000; (2):CD001211. PubMed ID: 10796757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
    Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
    Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.
    Lichtenstein SJ; De Leon L; Heller W; Marshall B; Cupp G; Foster K; McLean C; Levy S; Stroman DW
    J Pediatr Ophthalmol Strabismus; 2012; 49(2):88-97. PubMed ID: 22074357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjunctivitis: a systematic review of diagnosis and treatment.
    Azari AA; Barney NP
    JAMA; 2013 Oct; 310(16):1721-9. PubMed ID: 24150468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Acute Gonococcal Conjunctivitis in an Unusual Age Group.
    Rana RS; Gurung R
    Nepal J Ophthalmol; 2021 Jan; 13(25):137-140. PubMed ID: 33981108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
    Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
    Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial conjunctivitis and of antibiotics in Dhulikhel Hospital-Kathmandu University Hospital.
    Sthapit PR; Tuladhar NR; Marasini S; Khoju U; Thapa G
    Kathmandu Univ Med J (KUMJ); 2011; 9(34):69-72. PubMed ID: 22610873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).
    Block SL; Hedrick J; Tyler R; Smith A; Findlay R; Keegan E; Stroman DW
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1650-4. PubMed ID: 10817723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal Bacterial Conjunctivitis in Korea in the 21st Century.
    Pak KY; Kim SI; Lee JS
    Cornea; 2017 Apr; 36(4):415-418. PubMed ID: 28002109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonococcal Conjunctivitis: A Case Report of an Unusual Mode of Transmission.
    Bodurtha Smith AJ; Holzman SB; Manesh RS; Perl TM
    J Pediatr Adolesc Gynecol; 2017 Aug; 30(4):501-502. PubMed ID: 27871917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do general practitioners adhere to the guideline on infectious conjunctivitis? Results of the Second Dutch National Survey of General Practice.
    Rietveld RP; ter Riet G; Bindels PJ; Schellevis FG; van Weert HC
    BMC Fam Pract; 2007 Sep; 8():54. PubMed ID: 17868475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children.
    Hu YL; Lee PI; Hsueh PR; Lu CY; Chang LY; Huang LM; Chang TH; Chen JM
    Sci Rep; 2021 Jan; 11(1):11. PubMed ID: 33420151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotics versus placebo for acute bacterial conjunctivitis.
    Sheikh A; Hurwitz B; van Schayck CP; McLean S; Nurmatov U
    Cochrane Database Syst Rev; 2012 Sep; (9):CD001211. PubMed ID: 22972049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microbial structure of acute bacterial conjunctivitis].
    Chikviladze D; Nikuradze N; Gachechiladze Kh; Miqeladze M; Metreveli D
    Georgian Med News; 2013 Mar; (216):12-5. PubMed ID: 23567301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chlamydial conjunctivitis.
    Nakagawa H
    Ophthalmologica; 1997; 211 Suppl 1():25-8. PubMed ID: 9065934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
    Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
    Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management strategies for acute infective conjunctivitis in primary care: a systematic review.
    Rose P
    Expert Opin Pharmacother; 2007 Aug; 8(12):1903-21. PubMed ID: 17696792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
    Tauber S; Cupp G; Garber R; Bartell J; Vohra F; Stroman D
    Adv Ther; 2011 Jul; 28(7):566-74. PubMed ID: 21681652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling contagious bacterial conjunctivitis.
    Lichtenstein SJ; Dorfman M; Kennedy R; Stroman D
    J Pediatr Ophthalmol Strabismus; 2006; 43(1):19-26. PubMed ID: 16491721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial conjunctivitis: a review for internists.
    Tarabishy AB; Jeng BH
    Cleve Clin J Med; 2008 Jul; 75(7):507-12. PubMed ID: 18646586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.